204 related articles for article (PubMed ID: 28429199)
21. Clinical significance of failure to lose weight 10 years after roux-en-y gastric bypass.
Hawkins RB; Mehaffey JH; McMurry TL; Kirby J; Malin SK; Schirmer B; Hallowell PT
Surg Obes Relat Dis; 2017 Oct; 13(10):1710-1716. PubMed ID: 28919184
[TBL] [Abstract][Full Text] [Related]
22. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
23. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
[TBL] [Abstract][Full Text] [Related]
24. Changes in Health-Related Quality of Life After Gastric Bypass in Patients With and Without Obesity-Related Disease.
Risstad H; Søvik TT; Hewitt S; Kristinsson JA; Fagerland MW; Bernklev T; Mala T
Obes Surg; 2015 Dec; 25(12):2408-16. PubMed ID: 26003550
[TBL] [Abstract][Full Text] [Related]
25. Medium to long-term outcomes of bariatric surgery in older adults with super obesity.
Elbahrawy A; Bougie A; Loiselle SE; Demyttenaere S; Court O; Andalib A
Surg Obes Relat Dis; 2018 Apr; 14(4):470-476. PubMed ID: 29249586
[TBL] [Abstract][Full Text] [Related]
26. Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.
Perysinakis I; Pappis HC; Margaris E
Obes Surg; 2019 Mar; 29(3):1058-1067. PubMed ID: 30617917
[TBL] [Abstract][Full Text] [Related]
27. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Shouhed D; Steggerda J; Burch M; Noureddin M
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
[TBL] [Abstract][Full Text] [Related]
28. The first Polish liver transplantation after Roux-en-Y gastric bypass surgery for morbid obesity: a case report and literature review.
Marszałek R; Ziemiański P; Łągiewska B; Pacholczyk M; Domienik-Karłowicz J; Trzebicki J; Wierzbicki Z; Jankowski K; Kosieradzki M; Wasiak D; Jonas M; Pruszczyk P; Durlik M; Lisik W; Chmura A
Ann Transplant; 2015 Feb; 20():112-5. PubMed ID: 25711520
[TBL] [Abstract][Full Text] [Related]
29. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
30. Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss.
McKenna D; Selzer D; Burchett M; Choi J; Mattar SG
Surg Obes Relat Dis; 2014; 10(4):654-9. PubMed ID: 24708909
[TBL] [Abstract][Full Text] [Related]
31. Endothelial Function of Patients with Morbid Obesity Submitted to Roux-en-Y Gastric Bypass With and Without Obstructive Sleep Apnea-Hypopnea Syndrome.
de Assunção Machado AC; da Silva AMV; Signori LU; da Costa Alvarez G; Mottin CC
Obes Surg; 2018 Nov; 28(11):3595-3603. PubMed ID: 30054874
[TBL] [Abstract][Full Text] [Related]
32. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
33. Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study.
Kreve F; Callejas GH; Jimenez LS; Marques RA; Chaim FDM; Utrini MP; Gestic MA; Ramos AC; Chaim EA; Cazzo E
Sao Paulo Med J; 2022; 140(6):739-746. PubMed ID: 36102453
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery.
Corey KE; Stanley TL; Misdraji J; Scirica C; Pratt J; Hoppin A; Misra M
Pediatr Obes; 2014 Oct; 9(5):e91-3. PubMed ID: 24677740
[TBL] [Abstract][Full Text] [Related]
35. BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?
Goldoni MB; Fontes PRO; GuimarÃes MM; Diedrich-Neto JA; Nogueira T; Teixeira UF; Giacomazzi CB; Kiss G; Pioner SR; Rodrigues PD
Arq Bras Cir Dig; 2021; 33(3):e1549. PubMed ID: 33470379
[TBL] [Abstract][Full Text] [Related]
36. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
[TBL] [Abstract][Full Text] [Related]
38. Effect of primary versus revisional Roux-en-Y gastric bypass: inferior weight loss of revisional surgery after gastric banding.
Slegtenhorst BR; van der Harst E; Demirkiran A; de Korte J; Schelfhout LJ; Klaassen RA
Surg Obes Relat Dis; 2013; 9(2):253-8. PubMed ID: 22480750
[TBL] [Abstract][Full Text] [Related]
39. A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.
Jammu GS; Sharma R
Obes Surg; 2016 May; 26(5):926-32. PubMed ID: 26337694
[TBL] [Abstract][Full Text] [Related]
40. Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery.
Zhang YX; Yang L; Yang CC; Wang WY; Shen JH; Shi ML; Yu Y; Dai QC; Gu Y; Yang JJ; Yu WW; Yao K; Hu M; Ni J; Sun JL; Zhang L; Sun HX; Lu XF; Wang B
Obes Surg; 2020 Oct; 30(10):3803-3812. PubMed ID: 32529354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
